Reata

Biogen's M&A, Alzheimer's drug launch costs spark profit forecast cut
Reuters
Wed, 11/8/23 - 11:35 am
Biogen
Alzheimer's disease
Leqembi
Reata
M&A
earnings
Reata’s bardoxolone hits goals in phase 2 kidney disease trial
Fierce Biotech
Tue, 09/25/18 - 09:46 am
Reata
kidney disease
Bardoxolone
clinical trials
Show me the money: Which drugs made the top 10 list on upfront deals?
Fierce Biotech
Mon, 05/12/14 - 09:36 am
biotech
GED-0301
Celgene
Nogra Pharma
AbbVie
Reata
Bardoxolone
Abbott Labs
Tradjenta
Eli Lilly
Boehringer Ingelheim
FG-4592
AstraZeneca
FibroGen
Pfizer
Bristol-Myers Squibb
Eliquis
Moderna
Forma Therapeutics
dimebon
Medivation
Jakafi
Novartis
Incyte
Abbott, Reata kidney disease drug trial stopped
Reuters
Thu, 10/18/12 - 11:42 am
Abbott
Reata
kidney disease
Bardoxolone
AbbVie
Humira
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Abbott pays $400 mln to extend drug deal with Reata
Reuters
Mon, 12/12/11 - 10:38 am
Reata
Abbott Laboratories
FierceBiotech's 2011 Fierce 15 Biotech Companies
Fierce Biotech
Wed, 09/7/11 - 11:28 am
Blueprint Medicines
Cerulean
Cerenis Therapeutics
Epizyme
Forma Therapeutics
Intrexon
Merrimack Pharmaceuticals
f-star
Pfenex
Pearl Therapeutics
Reata
Selecta
Rib-X Pharmaceuticals
Tesaro
Theraclone
New Data on Abbott Kidney Drug Candidate
Yahoo/Zacks.com
Tue, 06/28/11 - 11:35 pm
Abbott Laboratories
Shire
Sanofi
bardoxolone methyl
Reata
kidney disease
Private Biotechs Take Different Avenues to Rake in Cash
Seeking Alpha
Sun, 09/26/10 - 12:45 pm
Reata
Abbott Laboratories
Bardoxolone
chronic kidney disease
Asthmatx
Boston Scientific
CytomX
Emergent BioSolutions
Reata-Abbott deal may be worth $800M-plus
Bizjournals.com
Thu, 09/23/10 - 02:55 pm
Abbott Laboratories
Reata
drug development